Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Milestone Scientific (MLSS) over the last 14 years, with Q3 2025 value amounting to -$4556.0.

  • Milestone Scientific's Cash from Financing Activities fell 7556.84% to -$4556.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $787226.0, marking a year-over-year decrease of 7192.0%. This contributed to the annual value of $233771.0 for FY2024, which is 9087.09% down from last year.
  • As of Q3 2025, Milestone Scientific's Cash from Financing Activities stood at -$4556.0, which was down 7556.84% from $796583.0 recorded in Q2 2025.
  • Over the past 5 years, Milestone Scientific's Cash from Financing Activities peaked at $3.7 million during Q1 2021, and registered a low of -$4556.0 during Q3 2025.
  • Its 5-year average for Cash from Financing Activities is $429736.5, with a median of -$2162.0 in 2023.
  • In the last 5 years, Milestone Scientific's Cash from Financing Activities tumbled by 10286.73% in 2022 and then skyrocketed by 12484348.88% in 2023.
  • Quarter analysis of 5 years shows Milestone Scientific's Cash from Financing Activities stood at $673943.0 in 2021, then plummeted by 100.31% to -$2058.0 in 2022, then soared by 124843.49% to $2.6 million in 2023, then tumbled by 100.1% to -$2523.0 in 2024, then plummeted by 80.58% to -$4556.0 in 2025.
  • Its last three reported values are -$4556.0 in Q3 2025, $796583.0 for Q2 2025, and -$2278.0 during Q1 2025.